314 related articles for article (PubMed ID: 18772244)
1. Epithelial ovarian cancer: testing the 'androgens hypothesis'.
Olsen CM; Green AC; Nagle CM; Jordan SJ; Whiteman DC; Bain CJ; Webb PM;
Endocr Relat Cancer; 2008 Dec; 15(4):1061-8. PubMed ID: 18772244
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
3. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
4. Alcohol, wine, and risk of epithelial ovarian cancer.
Webb PM; Purdie DM; Bain CJ; Green AC
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):592-9. PubMed ID: 15066924
[TBL] [Abstract][Full Text] [Related]
5. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
7. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
[TBL] [Abstract][Full Text] [Related]
8. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.
Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM
Int J Cancer; 2008 Jul; 123(2):450-456. PubMed ID: 18449887
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women.
Yang JH; Weng SL; Lee CY; Chou SY; Hsu CS; Hsu MI
Arch Gynecol Obstet; 2010 Sep; 282(3):327-33. PubMed ID: 20431891
[TBL] [Abstract][Full Text] [Related]
10. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
Riman T; Nilsson S; Persson IR
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
[TBL] [Abstract][Full Text] [Related]
11. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
Rosenfield RL; Lucky AW
Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
13. Body size and risk of epithelial ovarian cancer (United States).
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG; Weiss NS
Cancer Causes Control; 2006 Jun; 17(5):713-20. PubMed ID: 16633919
[TBL] [Abstract][Full Text] [Related]
14. Elevated rates of testosterone-related disorders in women with autism spectrum conditions.
Ingudomnukul E; Baron-Cohen S; Wheelwright S; Knickmeyer R
Horm Behav; 2007 May; 51(5):597-604. PubMed ID: 17462645
[TBL] [Abstract][Full Text] [Related]
15. Androgens and women's health.
Redmond GP
Int J Fertil Womens Med; 1998; 43(2):91-7. PubMed ID: 9609208
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of oral hirsutism in a patient with polycystic ovarian syndrome.
Femiano F; Rullo R; Serpico R; Lanza A; Festa VM; Laino G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):e13-6. PubMed ID: 19913714
[TBL] [Abstract][Full Text] [Related]
18. Height, age at menarche, and risk of epithelial ovarian cancer.
Jordan SJ; Webb PM; Green AC
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2045-8. PubMed ID: 16103459
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
20. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
